Dave Stieb

Effects of particulate and gaseous air pollution on cardiorespiratory hospitalizations.

We obtained data on daily numbers of admissions to hospital in Toronto, Canada, from 1980 to 1994 for respiratory, cardiac, cerebral vascular, and peripheral vascular diseases. We then linked the data to daily measures of particulate mass less than 10 microns in aerodynamic diameter (PM10), particulate mass less than 2.5 microns in aerodynamic diameter (PM2.5), and particulate mass between 2.5 and 10 microns in aerodynamic diameter (PM10-2.5), ozone, carbon monoxide, nitrogen dioxide, and sulfur dioxide. Air pollution was only associated weakly with hospitalization for cerebral vascular and peripheral vascular diseases. We controlled for temporal trends and climatic factors, and we found that increases of 10 microg/m3 in PM10, PM2.5, and PM10-2.5 were associated with 1.9%, 3.3%, and 2.9% respective increase in respiratory and cardiac hospital admissions. We further controlled for gaseous pollutants, and the percentages were reduced to 0.50%, 0.75%, and 0.77%, respectively. Of the 7.72 excess daily hospital admissions in Toronto attributable to the atmospheric pollution mix, 11.8% resulted from PM2.5, 8.2% to PM10-2.5, 17% to carbon monoxide, 40.4% to nitrogen dioxide, 2.8% to sulfur dioxide, and 19.8% to ozone.

A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada.

Background Chronic exposure to traffic-related air pollution (TRAP) may contribute to premature mortality, but few studies to date have addressed this topic. Objectives In this study we assessed the association between TRAP and mortality in Toronto, Ontario, Canada. Methods We collected nitrogen dioxide samples over two seasons using duplicate two-sided Ogawa passive diffusion samplers at 143 locations across Toronto. We calibrated land use regressions to predict NO2 exposure on a fine scale within Toronto. We used interpolations to predict levels of particulate matter with aerodynamic diameter ≤ 2.5 μm (PM2.5) and ozone levels. We assigned predicted pollution exposures to 2,360 subjects from a respiratory clinic, and abstracted health data on these subjects from medical billings, lung function tests, and diagnoses by pulmonologists. We tracked mortality between 1992 and 2002. We used standard and multilevel Cox proportional hazard models to test associations between air pollution and mortality. Results After controlling for age, sex, lung function, obesity, smoking, and neighborhood deprivation, we observed a 17% increase in all-cause mortality and a 40% increase in circulatory mortality from an exposure contrast across the interquartile range of 4 ppb NO2. We observed no significant associations with other pollutants. Conclusions Exposure to TRAP was significantly associated with increased all-cause and circulatory mortality in this cohort. A high prevalence of cardiopulmonary disease in the cohort probably limits inference of the findings to populations with a substantial proportion of susceptible individuals.

Associations between short-term changes in nitrogen dioxide and mortality in Canadian cities.

The association between daily variations in ambient concentrations of nitrogen dioxide (NO2) and mortality was examined in 12 of Canadas largest cities, using a 19-yr time-series analysis (from 1981-1999). The authors employed parametric statistical methods that are not subject to the recently discovered convergence and error estimation problems of generalized additive models. An increase in the 3-d moving average of NO2 concentrations equivalent to the population-weighted study mean of 22.4 ppb was associated with a 2.25% (t = 4.45) increase in the daily nonaccidental mortality rate and was insensitive to adjustment for ozone, sulfur dioxide, carbon monoxide, coefficient of haze, size-fractionated particulate mass, and the sulfate ion measured on an every-6th-day sampling schedule. The 3-d moving average of NO2 was sensitive to adjustment for fine particulate matter measured daily during the 1998-2000 time period.

From good intentions to proven interventions: effectiveness of actions to reduce the health impacts of air pollution.

Background Associations between air pollution and a multitude of health effects are now well established. Given ubiquitous exposure to some level of air pollution, the attributable health burden can be high, particularly for susceptible populations. Objectives An international multidisciplinary workshop was convened to discuss evidence of the effectiveness of actions to reduce health impacts of air pollution at both the community and individual level. The overall aim was to summarize current knowledge regarding air pollution exposure and health impacts leading to public health recommendations. Discussion During the workshop, experts reviewed the biological mechanisms of action of air pollution in the initiation and progression of disease, as well as the state of the science regarding community and individual-level interventions. The workshop highlighted strategies to reduce individual baseline risk of conditions associated with increased susceptibility to the effects of air pollution and the need to better understand the role of exposure duration in disease progression, reversal, and adaptation. Conclusion We have identified two promising and largely unexplored strategies to address and mitigate air pollution–related health impacts: reducing individual baseline risk of cardiovascular disease and incorporating air pollution–related health impacts into land-use decisions.

Impact of Particulate Air Pollution on Quality-Adjusted Life Expectancy in Canada

Air pollution and premature death are important public health concerns. Analyses have repeatedly demonstrated that airborne particles are associated with increased mortality and estimates have been used to forecast the impact on life expectancy. In this analysis, we draw upon data from the American Cancer Society (ACS) cohort and literature on utility-based measures of quality of life in relation to health status to more fully quantify the effects of air pollution on mortality in terms of quality-adjusted life expectancy. The analysis was conducted within a decision analytic model using Monte Carlo simulation techniques. Outcomes were estimated based on projections of the Canadian population. A one-unit reduction in sulfate air pollution would yield a mean annual increase in Quality-Adjusted Life Years (QALYs) of 20,960, with gains being greater for individuals with lower educational status and for males compared to females. This suggests that the impact of reductions in sulfate air pollution on quality-adjusted life expectancy is substantial. Interpretation of the results is unclear. However, the potential gains in QALYs from reduced air pollutants can be contrasted to the costs of policies to bring about such reductions. Based on a tentative threshold for the value of health benefits, analysis suggests that an investment in Canada of over

Measuring Progress in the Management of Ambient Air Quality: The Case for Population Health

1 billion per annum would be an efficient use of resources if it could be demonstrated that this would reduce sulfate concentrations in ambient air by 1 w g/m 3 . Further analysis can assess the efficiency of targeting such initiatives to communities that are most likely to benefit.

The association between ambient air quality and cardiac rate and rhythm in ambulatory subjects

Although progress has been made in the last few decades at reducing ambient concentrations of air pollutants, scientific evidence suggests that there remains a risk to human health from exposure to these pollutants at current levels in Canada. Much of the motivation for air pollution reduction efforts is to protect population health. This article presents a method of monitoring changes in air pollution-related health outcomes over time in conjunction with temporal changes in ambient pollution concentrations. The progress measure is a function of temporal changes in location-specific ambient concentrations and the potentially time-dependent association between those concentrations and daily deaths. The progress measure can be determined for a single location or at a national level. The measure can also be extended to include several pollutants. The progress measure is illustrated with an example of how changes in nitrogen dioxide levels in 12 Canadian cities from 1981 to 1999 have translated into changes in the percent of nonaccidental mortality burden attributable to this pollutant over time.

Biomass Burning as a Source of Ambient Fine Particulate Air Pollution and Acute Myocardial Infarction.

BACKGROUND Acute increases in ambient air pollution have been associated with increased hospitalization for cardiac diseases and stroke. Triggering of cardiac arrhythmia by changes in air quality could theoretically predispose individuals to cardiac arrest or heart failure, or stroke through precipitation of atrial fibrillation. We investigated the association between air quality and cardiac rate and rhythm characteristics measured by ambulatory cardiac monitoring. METHODS AND RESULTS Daily ambient 3-h maximum concentrations of ozone, nitrogen dioxide and fine particulate matter, and an index summarizing these pollutants called the Air Quality Health Index (AQHI) were compared to the results of 24-h ambulatory cardiac monitoring performed for clinical purposes in 8662 patients and analyzed at the University of Ottawa Heart Institute, Canada, between 2004 and 2009. An interquartile increase in the daily 3 h- maximum AQHI was associated with a 0.9% (95% CI 0.3%, 1.5%) increase in the daily maximum heart rate and a 1.17% (95% CI 1.07%, 1.29%) increase in heart block frequency. An interquartile increase in NO2 was associated with an increase in the percentage of time in atrial fibrillation of 4.39% (-0.15, 9.15) among those ≤50 years old, and 7.1% (0.24, 14.5) among males. CONCLUSIONS We found evidence that air pollution may affect cardiac rate and rhythm. This may be one mechanism partially explaining the increase in strokes and cardiac events observed on days of higher air pollution.

Perspectives on Air Quality Policy Issues in Europe and North America

Background: Biomass burning is an important source of ambient fine particulate air pollution (PM2.5) in many regions of the world. Methods: We conducted a time-stratified case-crossover study of ambient PM2.5 and hospital admissions for myocardial infarction (MI) in three regions of British Columbia, Canada. Daily hospital admission data were collected between 2008 and 2015 and PM2.5 data were collected from fixed site monitors. We used conditional logistic regression models to estimate odds ratios (ORs) describing the association between PM2.5 and the risk of hospital admission for MI. We used stratified analyses to evaluate effect modification by biomass burning as a source of ambient PM2.5 using the ratio of levoglucosan/PM2.5 mass concentrations. Results: Each 5 µg/m3 increase in 3-day mean PM2.5 was associated with an increased risk of MI among elderly subjects (≥65 years; OR = 1.06, 95% CI: 1.03, 1.08); risk was not increased among younger subjects. Among the elderly, the strongest association occurred during colder periods (<6.44°C); when we stratified analyses by tertiles of monthly mean biomass contributions to PM2.5 during cold periods, ORs of 1.19 (95% CI: 1.04, 1.36), 1.08 (95% CI: 1.06, 1.09), and 1.04 (95% CI: 1.03, 1.06) were observed in the upper, middle, and lower tertiles (Ptrend = 0.003), respectively. Conclusion: Short-term changes in ambient PM2.5 were associated with an increased risk of MI among elderly subjects. During cold periods, increased biomass burning contributions to PM2.5 may modify its association with MI.

Tracking national and regional spatial-temporal mortality risk associated with NO2 concentrations in Canada: a Bayesian hierarchical two-level model.

This article presents an overview of progress and future directions in air quality management in Europe, the United States, and Canada. The article describes the role of the European Commission, the Clean Air for Europe program, and the World Health Organization (WHO) in devising policies to reduce health risks due to air pollution in Europe. U.S. Environmental Protection Agency (EPA) standards for particulate matter (PM), air quality monitoring programs, and research efforts to support air quality management strategies are discussed. The unique aspects of air quality management in Canada are identified, including the need for a better understanding of the true burden of health effects and improved communication strategies to inform the public and stakeholders.